Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

European Journal of Cancer, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Scientific Reports, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Mynster Kronborg T., Webel H., O’Connell M. et al.

Olink Target 96HepatologyPatient StratificationPlasma

Journal of Applied Physiology, 2023
Type 2 diabetes exacerbates changes in blood pressure-independent arterial stiffness: cross-sectional and longitudinal evidence from the SUMMIT study

Aizawa K., Gates P., Mawson D. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Translational Neurodegeneration, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease

Faridar A., Eid A., Thome A. et al.

Olink Target 48NeurologyImmunotherapyPathophysiologyPlasma

European Journal of Heart Failure, 2023
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

Ferreira J., Packer M., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Frontiers in Endocrinology, 2023
Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome

Pascut D., Giraudi P., Banfi C. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationSerum

PLOS ONE, 2023
Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn A., Eriksson N., Assarsson E. et al.

Olink FocusCVDPathophysiologyPatient StratificationPlasma

Journal of Experimental & Clinical Cancer Research, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Wimmer K., Sachet M., Ramos C. et al.

Olink Target 96OncologyPathophysiologyPlasma

International Journal of Hygiene and Environmental Health, 2023
Joint association of air pollution exposure and inflammation-related proteins in relation to infant lung function

He S., Lundberg B., Hallberg J. et al.

Olink Target 96Respiratory DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2023
Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia

Michels E., Appelman B., de Brabander J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Clinical and Translational Medicine, 2023
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis

Meng H., Sengupta A., Ricciotti E. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

European Heart Journal, 2023
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

Müller F., Aherrahrou Z., Grasshoff H. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologyBlood

ESC Heart Failure, 2023
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

Santos‐Ferreira D., Diaz S., Ferreira J. et al.

Olink Target 96CVDPathophysiologyPlasma

BMC Cancer, 2023
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study

Hau S., Svensson M., Petersson A. et al.

Olink Target 96OncologyPatient StratificationSerum

iScience, 2023
TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion

Steitz A., Schröder C., Knuth I. et al.

Olink Explore 3072/384OncologyPathophysiologyCell Culture Supernatant

Journal of Cardiac Failure, 2023
Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial

Razaghizad A., Aziz H., Zhang G. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Journal of the American College of Cardiology, 2023
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease

Mazidi M., Wright N., Yao P. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Journal of the American College of Cardiology, 2023
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Ouwerkerk W., Belo Pereira J., Maasland T. et al.

Olink Target 96CVDPathophysiologyPlasma

Nature Genetics, 2023
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

Stacey S., Zink F., Halldorsson G. et al.

Olink Explore 3072/384HematologyEpidemiologyPlasma

Translational Vision Science & Technology, 2023
Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases

Wilson S., Siebourg-Polster J., Titz B. et al.

Olink Target 96OphthalmologyTechnical EvaluationSerumAqueous HumorVitreous

1889 publications